DE60226517D1 - Dipeptidyl peptidase iv inhibitoren zur senkung der chronische gewichtszunahme - Google Patents
Dipeptidyl peptidase iv inhibitoren zur senkung der chronische gewichtszunahmeInfo
- Publication number
- DE60226517D1 DE60226517D1 DE60226517T DE60226517T DE60226517D1 DE 60226517 D1 DE60226517 D1 DE 60226517D1 DE 60226517 T DE60226517 T DE 60226517T DE 60226517 T DE60226517 T DE 60226517T DE 60226517 D1 DE60226517 D1 DE 60226517D1
- Authority
- DE
- Germany
- Prior art keywords
- cells
- pancreatic
- inhibitors
- dipeptidyl peptidase
- weight increases
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/426—1,3-Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Diabetes (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pyrrole Compounds (AREA)
- Peptides Or Proteins (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/EP2002/008931 WO2004017989A1 (en) | 2002-08-09 | 2002-08-09 | Methods for improving islet signaling in diabetes mellitus and for its prevention |
Publications (1)
Publication Number | Publication Date |
---|---|
DE60226517D1 true DE60226517D1 (de) | 2008-06-19 |
Family
ID=31896800
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE60226517T Expired - Lifetime DE60226517D1 (de) | 2002-08-09 | 2002-08-09 | Dipeptidyl peptidase iv inhibitoren zur senkung der chronische gewichtszunahme |
Country Status (10)
Country | Link |
---|---|
EP (1) | EP1528931B1 (de) |
AT (1) | ATE394118T1 (de) |
AU (1) | AU2002331226A1 (de) |
CY (1) | CY1108769T1 (de) |
DE (1) | DE60226517D1 (de) |
DK (1) | DK1528931T3 (de) |
ES (1) | ES2306781T3 (de) |
PT (1) | PT1528931E (de) |
SI (1) | SI1528931T1 (de) |
WO (1) | WO2004017989A1 (de) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2518465A1 (en) | 2003-03-25 | 2004-10-14 | Takeda San Diego, Inc. | Dipeptidyl peptidase inhibitors |
US7169926B1 (en) | 2003-08-13 | 2007-01-30 | Takeda Pharmaceutical Company Limited | Dipeptidyl peptidase inhibitors |
US7678909B1 (en) | 2003-08-13 | 2010-03-16 | Takeda Pharmaceutical Company Limited | Dipeptidyl peptidase inhibitors |
US7723344B2 (en) | 2003-08-13 | 2010-05-25 | Takeda San Diego, Inc. | Dipeptidyl peptidase inhibitors |
EP1699777B1 (de) | 2003-09-08 | 2012-12-12 | Takeda Pharmaceutical Company Limited | Dipeptidylpeptidase-hemmer |
US7732446B1 (en) | 2004-03-11 | 2010-06-08 | Takeda Pharmaceutical Company Limited | Dipeptidyl peptidase inhibitors |
GEP20094679B (en) | 2004-03-15 | 2009-05-10 | Takeda Pharmaceuticals Co | Dipeptidyl peptidase inhibitors |
JP2008501714A (ja) | 2004-06-04 | 2008-01-24 | 武田薬品工業株式会社 | ジペプチジルペプチダーゼインヒビター |
WO2006019965A2 (en) | 2004-07-16 | 2006-02-23 | Takeda San Diego, Inc. | Dipeptidyl peptidase inhibitors |
EP2805953B1 (de) | 2004-12-21 | 2016-03-09 | Takeda Pharmaceutical Company Limited | Dipeptidyl-Peptidase-Hemmer |
GEP20135838B (en) | 2005-09-14 | 2013-06-10 | Takeda Pharmaceutical | Dipeptidyl peptidase inhibitors usage at diabetes treatment |
CA2622642C (en) | 2005-09-16 | 2013-12-31 | Takeda Pharmaceutical Company Limited | Dipeptidyl peptidase inhibitors |
WO2007112347A1 (en) | 2006-03-28 | 2007-10-04 | Takeda Pharmaceutical Company Limited | Dipeptidyl peptidase inhibitors |
US8324383B2 (en) | 2006-09-13 | 2012-12-04 | Takeda Pharmaceutical Company Limited | Methods of making polymorphs of benzoate salt of 2-[[6-[(3R)-3-amino-1-piperidinyl]-3,4-dihydro-3-methyl-2,4-dioxo-1(2H)-pyrimidinyl]methyl]-benzonitrile |
TW200838536A (en) | 2006-11-29 | 2008-10-01 | Takeda Pharmaceutical | Polymorphs of succinate salt of 2-[6-(3-amino-piperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-ylmethy]-4-fluor-benzonitrile and methods of use therefor |
US8093236B2 (en) | 2007-03-13 | 2012-01-10 | Takeda Pharmaceuticals Company Limited | Weekly administration of dipeptidyl peptidase inhibitors |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TW492957B (en) * | 1996-11-07 | 2002-07-01 | Novartis Ag | N-substituted 2-cyanopyrrolidnes |
US6803357B1 (en) * | 1998-02-02 | 2004-10-12 | New England Medical Center Hospitals, Inc. | Method of regulating glucose metabolism, and reagents related thereto |
DE19823831A1 (de) * | 1998-05-28 | 1999-12-02 | Probiodrug Ges Fuer Arzneim | Neue pharmazeutische Verwendung von Isoleucyl Thiazolidid und seinen Salzen |
DE19828113A1 (de) * | 1998-06-24 | 2000-01-05 | Probiodrug Ges Fuer Arzneim | Prodrugs von Inhibitoren der Dipeptidyl Peptidase IV |
DE19828114A1 (de) | 1998-06-24 | 2000-01-27 | Probiodrug Ges Fuer Arzneim | Produgs instabiler Inhibitoren der Dipeptidyl Peptidase IV |
DE19834591A1 (de) * | 1998-07-31 | 2000-02-03 | Probiodrug Ges Fuer Arzneim | Verfahren zur Steigerung des Blutglukosespiegels in Säugern |
US6881564B1 (en) | 1999-09-10 | 2005-04-19 | The University Of Sydney | Dipeptidyl peptidases |
PT2055302E (pt) * | 2000-03-31 | 2014-12-03 | Royalty Pharma Collection Trust | Processo para a melhoria da sinalização de ilhéus em diabetes mellitus e para a sua prevenção |
TW583185B (en) * | 2000-06-13 | 2004-04-11 | Novartis Ag | N-(substituted glycyl)-2-cyanopyrrolidines and pharmaceutical composition for inhibiting dipeptidyl peptidase-IV (DPP-IV) or for the prevention or treatment of diseases or conditions associated with elevated levels of DPP-IV comprising the same |
WO2002004610A2 (en) | 2000-07-10 | 2002-01-17 | Bayer Aktiengesellschaft | Regulation of human dipeptidyl-peptidase iv-like enzyme |
CA2425001A1 (en) | 2000-10-12 | 2002-04-18 | Ferring Bv | Novel serine protease genes related to dppiv |
AUPR107800A0 (en) | 2000-10-27 | 2000-11-23 | University Of Sydney, The | Peptide and nucleic acid molecule ii |
-
2002
- 2002-08-09 DK DK02767358T patent/DK1528931T3/da active
- 2002-08-09 AT AT02767358T patent/ATE394118T1/de active
- 2002-08-09 AU AU2002331226A patent/AU2002331226A1/en not_active Abandoned
- 2002-08-09 DE DE60226517T patent/DE60226517D1/de not_active Expired - Lifetime
- 2002-08-09 ES ES02767358T patent/ES2306781T3/es not_active Expired - Lifetime
- 2002-08-09 WO PCT/EP2002/008931 patent/WO2004017989A1/en active IP Right Grant
- 2002-08-09 PT PT02767358T patent/PT1528931E/pt unknown
- 2002-08-09 EP EP02767358A patent/EP1528931B1/de not_active Expired - Lifetime
- 2002-08-09 SI SI200230708T patent/SI1528931T1/sl unknown
-
2008
- 2008-07-31 CY CY20081100811T patent/CY1108769T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
ES2306781T3 (es) | 2008-11-16 |
ATE394118T1 (de) | 2008-05-15 |
CY1108769T1 (el) | 2014-04-09 |
SI1528931T1 (sl) | 2008-10-31 |
WO2004017989A1 (en) | 2004-03-04 |
DK1528931T3 (da) | 2008-09-08 |
AU2002331226A1 (en) | 2004-03-11 |
EP1528931A1 (de) | 2005-05-11 |
EP1528931B1 (de) | 2008-05-07 |
PT1528931E (pt) | 2008-08-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1108769T1 (el) | Αναστολεις της διπεπτιδυλικης πεπτιδασης iv για μειωση του ρυθμου της χρονιας αυξησης βαρους | |
DK1283735T3 (da) | Fremgangsmåde til fremstilling af hydrazon-derivater | |
RS53767B1 (en) | PROCEDURE FOR TREATMENT OF JOINT INJURY | |
CY1116463T1 (el) | Θεραπεια συνδυασμου για τη θεραπευτικη αγωγη διαταραχων ανεπαρκειας πρωτεϊνης | |
WO2005000215A3 (en) | Methods for treating pain | |
EA200800161A1 (ru) | Новые фармацевтические композиции с модифицированным высвобождением и способ получения таких композиций | |
ATE499098T1 (de) | Verwendung von parp-1-hemmern | |
CY1116164T1 (el) | Προδρομη 4-σουλφαταση ν-ακετυλογαλακτο σαμινης, μεθοδοι θεραπευτικης αγωγης που χρησιμοποιουν το εν λογω ενζυμο και μεθοδοι για παραγωγη και καθαρισμο του εν λογω ενζυμου | |
EA201000630A1 (ru) | Применение бензоконденсированных гетероциклических сульфамидных производных для понижения уровней липидов в крови | |
DE60108489D1 (de) | Kombinationstherapien mit gefässschädigender aktivität | |
ATE284698T1 (de) | Aktivierung natürlicher killerzellen durch adenosin-a3-rezeptoragonisten | |
EP1543158A4 (de) | Regulierte aptamer-therapeutika | |
WO2003033678A3 (en) | Methods of using deacetylase inhibitors to promote cell differentiation and regeneration | |
AR047726A1 (es) | Metodos y reactivos para el tratamiento de trastornos inflamatorios | |
DE69722809D1 (de) | Behandlung von stressinduzierten hautkrankheiten unter verwendung von corticoliberin (crh)-antagonisten und inhibitoren der hautmastzell-degranulation | |
WO2006031375A3 (en) | Use of intradiscally administered autologous cells producing type i interferon for the treatment of degenerative disc disease | |
WO2021239928A3 (en) | Treatment of cardiometabolic disease with inhibitors of type i interferon signalling | |
MXPA05010068A (es) | Promocion de la angiogenesis por composiciones de prostaglandina y metodos. | |
WO2010131909A3 (ko) | 호흡기 염증성 질환의 치료 또는 예방을 위한 호흡기내 투여용 약학 제제 및 상기 질환의 치료 또는 예방 방법 | |
MD3250G2 (ro) | Metodă de tratament al sindromului cheroto-conjunctivitei sica | |
ATE493144T1 (de) | Zusammensetzung und verfahren zur abtötung von tumoren | |
SE0402433D0 (sv) | New composition and method | |
Barnes¹ | Neural and humoral control of the airways | |
MY156431A (en) | Methods of treating proliferative skin diseases using carbazole derivatives |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
R082 | Change of representative |
Ref document number: 1528931 Country of ref document: EP Representative=s name: TER MEER STEINMEISTER & PARTNER GBR PATENTANWAELTE |